Infantile colic is associated with development of later constipation and atopic disorders

Jakob Stokholm1,2,3, Jonathan Thorsen1, Ann-Marie Malby Schoos1,3

  • 1Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.

Allergy
|August 20, 2024
PubMed

Insights

Infantile colic is linked to a higher risk of developing constipation and atopic conditions like asthma and eczema in early childhood. These risks are not explained by differences in the infant gut microbiome at one month old.

Area of Science:

  • Pediatric Health
  • Gastroenterology
  • Immunology

Background:

  • Infantile colic is a common condition with unclear long-term health implications.
  • Limited understanding exists regarding the connection between early life gut microbiome and later atopic or gastrointestinal disorders.

Purpose of the Study:

  • To investigate the role of the early life gut microbiome in infantile colic.
  • To assess the association between infantile colic and the subsequent development of atopic and gastrointestinal disorders up to age six.

Main Methods:

  • Utilized the Copenhagen Prospective Studies on Asthma in Childhood (2010) cohort, following 695 children for six years.
  • Analyzed the 1-month gut microbiome using 16S rRNA sequencing and assessed infantile colic via interviews at three months.
  • Evaluated clinical endpoints including constipation, asthma, atopic dermatitis, and allergic sensitization through age six.

Main Results:

  • Infantile colic occurred in 7.9% of children; while not directly linked to specific microbiome compositions, a model of nine species moderately predicted colic (AUC=0.627).
  • Children with infantile colic showed increased risks for later constipation (aOR=2.88), asthma (aHR=1.69), atopic dermatitis (aHR=1.84), and a higher number of allergic components.
  • These associations were not mediated by gut microbiome differences at one month of age.

Conclusions:

  • Infantile colic is associated with an increased risk of developing constipation and atopic disorders within the first six years of life.
  • The observed risks are not explained by alterations in the gut microbiome at one month of age.
  • These findings suggest that infantile colic may involve underlying gastrointestinal and/or atopic mechanisms independent of early microbiome composition.
Abstract

Related Concept Videos

Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
427
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
154
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
160
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
206
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
146
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
264